SCHEMBL12436779

SCHEMBL12436779

Cc1ccn(C(C)(C)C(=O)O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
MAPT P10636 4/20 0.37
RAB9A P51151 2/20 0.37
ATM Q13315 2/20 0.37
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NOS1 P29475 1/20 0.37
CYP4F2 P78329 2/20 0.37
CYP4A11 Q02928 2/20 0.37
ALDH1A1 P00352 2/20 0.37
USP2 O75604 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PLAU P00749 2/20 0.35
ELANE P08246 2/20 0.35
F2 P00734 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22305675 0.83 CYP4F2 (0.35) MAPTRAB9AATMNPC1SMN1; SMN2
SCHEMBL21241776 0.79 GAA (0.40) LMNAMAPTRAB9ASMN1; SMN2L3MBTL1
SCHEMBL21241772 0.79 CYP4F2 (0.43) MAPTRAB9AL3MBTL1NOS1CYP4F2
SCHEMBL23705537 0.78 LMNA (0.39) LMNACYP4F2CYP4A11KDM4E
SCHEMBL16427936 0.78 LMNA (0.39) LMNACYP4F2CYP4A11KDM4E
SCHEMBL24737152 0.77 NOS1 (0.41) MAPTRAB9AATMNPC1SMN1; SMN2
SCHEMBL2749111 0.76 MAPT (0.39) MAPTRAB9AATMNPC1SMN1; SMN2
SCHEMBL22971546 0.76 GAA (0.38) LMNACYP4F2CYP4A11ALDH1A1GAA
Pivalate SCHEMBL28032650 0.74 RAB9A (0.39) LMNAMAPTRAB9AATMNPC1
SCHEMBL29750493 0.73 ALDH1A1 (0.41) LMNAMAPTRAB9AATMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020160180-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2020-08-06 WO disclosed
WO-2019152437-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2019-08-08 WO disclosed
WO-2011095997-A1 BENZAMIDE COMPOUNDS AS GLUCOKINASE ACTIVATORS AND THEIR PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-08-11 WO disclosed